A detailed history of Tcg Advisory Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tcg Advisory Services, LLC holds 56,764 shares of ABBV stock, worth $9.49 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
56,764
Previous 58,648 3.21%
Holding current value
$9.49 Million
Previous $9.09 Million 13.73%
% of portfolio
0.57%
Previous 0.62%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $301,100 - $343,076
-1,884 Reduced 3.21%
56,764 $10.3 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $2.24 Million - $2.52 Million
16,293 Added 38.47%
58,648 $9.09 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $627,338 - $726,236
4,696 Added 12.47%
42,355 $6.31 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $982,429 - $1.22 Million
7,414 Added 24.51%
37,659 $5.07 Million
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $1.69 Million - $1.95 Million
11,694 Added 63.04%
30,245 $4.82 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $214,242 - $256,932
1,549 Added 9.11%
18,551 $3 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $235,001 - $269,531
1,751 Added 11.48%
17,002 $2.28 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $1.9 Million - $2.41 Million
13,795 Added 947.46%
15,251 $2.34 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $25,472 - $31,603
-193 Reduced 11.7%
1,456 $236,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $100,876 - $127,638
-939 Reduced 36.28%
1,649 $223,000
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $114,912 - $130,442
-1,080 Reduced 29.44%
2,588 $279,000
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $155,921 - $173,705
-1,482 Reduced 28.78%
3,668 $413,000
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $75,804 - $83,451
741 Added 16.81%
5,150 $557,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $354,880 - $479,126
4,409 New
4,409 $386,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tcg Advisory Services, LLC Portfolio

Follow Tcg Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Advisory Services, LLC with notifications on news.